Steven T. Rosen

Steven T. Rosen is the executive vice president and director emeritus of City of Hope's Beckman Research Institute and cancer center. He was previously the provost and chief scientific officer of City of Hope National Medical Center in Duarte, California. In addition to previously directing City of Hope's Comprehensive Cancer Center, he also led the Beckman Research Institute at City of Hope and the Irell & Manella Graduate School of Biological Sciences. Previously (1989-2014), Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.

In 2015 Rosen received a lifetime achievement award from the Israel Cancer Research Fund (ICRF) for his work in cancer research. His main areas of research involve the development of new treatments, particularly for Hematologic malignancies. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Steven T. Rosen', query time: 0.03s Refine Results
  1. 1
    Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors

    Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors by Metin Gunes, Steven T. Rosen, Steven T. Rosen, Idit Shachar, E. Gulsen Gunes, E. Gulsen Gunes, E. Gulsen Gunes

    Published 2024-02-01
    Get full text
    Article
  2. 2
    Function and mechanism of bispecific antibodies targeting SARS-CoV-2

    Function and mechanism of bispecific antibodies targeting SARS-CoV-2 by Zhaohui Li, Zengyuan Zhang, Steven T. Rosen, Mingye Feng

    Published 2024-04-01
    Get full text
    Article
  3. 3
    DNMT1 and p38γ are inversely expressed in reactive non‐metastatic lymph nodes burdened with colorectal adenocarcinoma

    DNMT1 and p38γ are inversely expressed in reactive non‐metastatic lymph nodes burdened with colorectal adenocarcinoma by Xu Hannah Zhang, Zhirong Yin, Aimin Zhang, Raju Pillai, Brian Armstrong, Steven T Rosen

    Published 2020-07-01
    Get full text
    Article
  4. 4
    Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation

    Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation by Dinh Hoa Hoang, Ralf Buettner, Melissa Valerio, Lucy Ghoda, Bin Zhang, Ya-Huei Kuo, Steven T. Rosen, John Burnett, Guido Marcucci, Vinod Pullarkat, Le Xuan Truong Nguyen

    Published 2022-06-01
    Get full text
    Article
  5. 5
    P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

    P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma by Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puvurel, Robert Chen, Leslie Popplewell, Liana Nikolaenko, Lacolle Peters, Saro Armenian, Larry Kwak, Steven T. Rosen, Stephen Forman, Alex F. Herrera

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides

    Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides by Cosimo Di Raimondo, Zhen Han, Chingyu Su, Xiwei Wu, Hanjun Qin, James F. Sanchez, Yate-Ching Yuan, Xochiquetzal Martinez, Farah Abdulla, Jasmine Zain, Chun-Wei Chen, Steven T. Rosen, Christiane Querfeld

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma

    Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti–PD-L1 and lenalidomide in cutaneous T cell lymphoma by Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Daniel Schmolze, Chingyu Su, Jasmine Zain, Lilach Moyal, Emmilia Hodak, James F. Sanchez, Peter P. Lee, Mingye Feng, Steven T. Rosen, Christiane Querfeld

    Published 2023-07-01
    Get full text
    Article
  8. 8
    P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma

    P112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma by Matthew Mei, Joycelynne Palmer, Kami Maddocks, Peter Martin, Ni-Chun Tsai, Eileen Smith, Leslie Popplewell, Saro Armenian, Geoffrey Shouse, Robert Chen, Larry Kwak, Steven T. Rosen, Stephen Forman, David Bond, Alex F. Herrera

    Published 2022-10-01
    Get full text
    Article
  9. 9
    COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome

    COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome by Syed Rahmanuddin, Asma Jamil, Ammar Chaudhry, Tyler Seto, Jordyn Brase, Pejman Motarjem, Marjaan Khan, Cristian Tomasetti, Umme Farwa, William Boswell, Haris Ali, Danielle Guidaben, Rafay Haseeb, Guibo Luo, Guido Marcucci, Steven T. Rosen, Wenli Cai

    Published 2023-01-01
    Get full text
    Article
  10. 10
    Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism

    Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism by Dinh Hoa Hoang, Corey Morales, Ivan Rodriguez Rodriguez, Melissa Valerio, Jiamin Guo, Min-Hsuan Chen, Xiwei Wu, David Horne, Varsha Gandhi, Lisa S. Chen, Bin Zhang, Vinod Pullarkat, Steven T. Rosen, Guido Marcucci, Ralf Buettner, Le Xuan Truong Nguyen

    Published 2022-03-01
    Get full text
    Article
  11. 11
    Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1‐EEF1A1 Axis

    Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1‐EEF1A1 Axis by Mingli Li, Lu Yang, Anthony K. N. Chan, Sheela Pangeni Pokharel, Qiao Liu, Nicole Mattson, Xiaobao Xu, Wen‐Han Chang, Kazuya Miyashita, Priyanka Singh, Leisi Zhang, Maggie Li, Jun Wu, Jinhui Wang, Bryan Chen, Lai N. Chan, Jaewoong Lee, Xu Hannah Zhang, Steven T. Rosen, Markus Müschen, Jun Qi, Jianjun Chen, Kevin Hiom, Alexander J. R. Bishop, Chun‐Wei Chen

    Published 2023-06-01
    Get full text
    Article
  12. 12
    Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia

    Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia by Anil Kumar, Min Huang, Norman J. Lacayo, Holden T. Maecker, Stephen J. Forman, Srividya Swaminathan, Caroline Duault, Jianhua Yu, Steven T. Rosen, Anthony Chan, Martin Carroll, Adeleh Taghi Khani, Soraya Aramburo, Ashly Sanchez Ortiz, Sung June Lee, Tinisha McDonald, Kathleen M. Sakamoto, Christian Hurtz, Sarah K. Tasian, Lucy Ghoda, Guido Marcucci, Zhaohui Gu, Saro Armenian, Shai Izraeli, Chun-Wei Chen, Michael A. Caligiuri

    Published 2023-05-01
    Get full text
    Article
  13. 13
    METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation

    METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation by Meilin Xue, Lei Dong, Honghai Zhang, Yangchan Li, Kangqiang Qiu, Zhicong Zhao, Min Gao, Li Han, Anthony K. N. Chan, Wei Li, Keith Leung, Kitty Wang, Sheela Pangeni Pokharel, Ying Qing, Wei Liu, Xueer Wang, Lili Ren, Hongjie Bi, Lu Yang, Chao Shen, Zhenhua Chen, Laleh Melstrom, Hongzhi Li, Nikolai Timchenko, Xiaolan Deng, Wendong Huang, Steven T. Rosen, Jingyan Tian, Lin Xu, Jiajie Diao, Chun-Wei Chen, Jianjun Chen, Baiyong Shen, Hao Chen, Rui Su

    Published 2024-02-01
    Get full text
    Article

Search Tools: